The Allergy Treatment Market has evolved from a largely symptom-control category into a broader care ecosystem that combines antihistamines, corticosteroids, decongestants, bronchodilator-linked allergy care, immunotherapy, biologics, and emergency anaphylaxis management across hospital, clinic, retail, and home-use settings. Demand is concentrated in allergic rhinitis, allergic asthma, food allergy, skin allergy, conjunctival allergy, and severe hypersensitivity management, with end use spanning hospitals, specialty allergy clinics, primary care, pharmacies, and increasingly self-managed outpatient care. A major trend shaping the sector is the shift from short-term symptomatic relief toward longer-duration disease management and more personalized treatment selection, especially in patients with recurrent, moderate-to-severe, or multi-trigger conditions. Immunotherapy remains especially important because it offers a disease-modifying pathway for selected inhalant allergies, while newer biologic approaches are expanding treatment options in severe and high-risk cases. Recent therapeutic progress in food allergy has also widened the market’s scope beyond avoidance and rescue care alone.